1. The role of 14-3-3β in acute asthma in children and analysis of the risk factors for asthma exacerbation.
- Author
-
Li S, Dong J, Li A, Yang Q, Xiong X, Xie X, and Zhang Y
- Subjects
- Humans, Male, Child, Female, Risk Factors, Child, Preschool, Acute Disease, ROC Curve, Immunoglobulin E blood, Logistic Models, Severity of Illness Index, Sensitivity and Specificity, Biomarkers blood, Adolescent, Case-Control Studies, Asthma blood, Asthma diagnosis, 14-3-3 Proteins blood
- Abstract
Objective: To investigate the role of 14-3-3β in acute asthma exacerbations in children and analyze the risk factors for asthma exacerbations., Methods: This study recruited 101 children with acute asthma exacerbations, 101 children with stable asthma, and 65 healthy children. Serum 14-3-3β was compared among the three groups. Factors such as asthma family history, skin prick test, serum-specific IgE test, coinfections, and clinical indicators (FeNO, FEV1, white blood cells, eosinophils, and serum IgE level) were compared between the asthma groups. Risk factors associated with acute asthma exacerbations were identified using multivariate logistic regression models. ROC curve was drawn to determine the diagnostic sensitivity and specificity of 14-3-3β., Results: Serum 14-3-3β was significantly greater in the acute asthma group than in the stable asthma and control groups. Serum 14-3-3β was higher in severe acute asthma group than in mild-moderate asthma group. There were no significant differences in serum 14-3-3β levels between stable asthma and control groups ( p > .05). Multivariate logistic regression analysis revealed that serum 14-3-3β level, FeNO, coinfection, and FEV1 z-score significantly increased the odds of acute asthma exacerbations in children. The optimal 14-3-3β cutoff value (39.79 ng/mL), had a sensitivity of 69.3% and specificity of 94.1% for predicting acute asthma exacerbations., Conclusions: 14-3-3β is elevated in children with acute exacerbations of asthma, and increases with exacerbation severity. 14-3-3β, FeNO, FEV1, and coinfection could be independent risk factors for predicting asthma exacerbations. The optimal 14-3-3β cutoff value for predicting asthma exacerbations was 39.79 ng/mL.
- Published
- 2024
- Full Text
- View/download PDF